Addex Therapeutics (ADXN) Institutional Ownership $7.28 -0.52 (-6.65%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Addex Therapeutics (NASDAQ:ADXN)CurrentInstitutional OwnershipPercentage16.14%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$84.55KNumber ofInstitutional Sellers(last 12 months)0 Get ADXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Addex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADXN Institutional Buying and Selling by Quarter Addex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC12,079$85K0.0%N/A1.140% 2/13/2024 Armistice Capital LLC43,000$260K0.0%-92.0%4.343% 11/15/2023 Armistice Capital LLC537,000$206K0.0%+103.4%65.328% 5/1/2023 Virtu Financial LLC42,912$41K0.0%+203.8%0.334% 2/14/2023 Susquehanna International Group LLP72,142$45K0.0%N/A0.561% 2/10/2023 NEA Management Company LLC1,080,000$113K0.0%-80.9%8.398% 11/14/2022 Armistice Capital LLC320,000$256K0.0%+26.5%2.941% 11/14/2022 NEA Management Company LLC5,648,690$830K0.0%+500.0%51.923% 8/5/2022 OLD Mission Capital LLC31,134$36K0.0%N/A0.286% 8/12/2021 New Leaf Venture Partners L.L.C.50,000$478K0.1%N/A0.609% 8/2/2021 NEA Management Company LLC180,000$17.21M0.2%N/A2.192% 5/21/2021 Citadel Advisors LLC11,604$121K0.0%N/A0.141% 5/18/2021 Citadel Advisors LLC11,604$121K0.0%N/A0.212% 5/12/2021 UBS Group AG2,520$26K0.0%+2,420.0%0.046% 2/16/2021 Caxton Corp265,940$3.56M2.2%+1,428.6%4.862% (Data available from 1/1/2016 forward) ADXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Addex Therapeutics shares: Armistice Capital LLC ($260K), and Citadel Advisors LLC ($85K), Virtu Financial LLC ($41K).Learn more on ADXN's institutional investors. What percentage of Addex Therapeutics stock is owned by institutional investors? 16.14% of Addex Therapeutics stock is owned by institutional investors. Learn more on ADXN's institutional investor holdings. Which institutional investors have been buying Addex Therapeutics stock? The following institutional investors have purchased Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($273K), Virtu Financial LLC ($28.79K), and Citadel Advisors LLC ($12.08K). How much institutional buying is happening at Addex Therapeutics? Institutional investors have bought a total of 313,868 shares in the last 24 months. This purchase volume represents approximately $2.73M in transactions. Which Addex Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Addex Therapeutics stock in the last 24 months: Armistice Capital LLC ($494K). How much institutional selling is happening at Addex Therapeutics? Institutional investors have sold a total of 494,000 shares in the last 24 months. This volume of shares sold represents approximately $2.99M in transactions. Related Companies Incannex Healthcare Major Shareholders Rallybio Major Shareholders ProMIS Neurosciences Major Shareholders CEL-SCI Major Shareholders Marinus Pharmaceuticals Major Shareholders NKGen Biotech Major Shareholders Pulmatrix Major Shareholders Chemomab Therapeutics Major Shareholders Lexaria Bioscience Major Shareholders Cyclo Therapeutics Major Shareholders This page (NASDAQ:ADXN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
